Chad A Brambley - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Chad A Brambley

Showing results (11-20 of 14) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 14 results.

Nature Communications|January 20, 2025

Dynamic allostery in the peptide/MHC complex enables TCR neoantigen selectivityJiaqi Ma, Cory M Ayres, Chad A Brambley, et al.

Biorxiv : the Preprint Server for Biology|February 26, 2024

Distinct sets of molecular characteristics define tumor-rejecting neoantigensAnngela C Adams, Anne M Macy, Elizabeth S Borden, et al.

Protein Engineering, Design & Selection : PEDS|February 28, 2026

Expansion of the known Poly(Aspartic Acid) Hydrolases through the Identification of Four New PahZ1 HomologsJustin D Marsee, Chad A Brambley, Thi Ho, et al.

Journal for Immunotherapy of Cancer|October 22, 2025

Structural changes from wild-type define tumor-rejecting neoantigensAnngela C Adams, Anne M Macy, Elizabeth S Borden, et al.

Pageof 2

Search research articles

Showing results (11-20 of 14) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 14 results.

Nature Communications|January 20, 2025

Dynamic allostery in the peptide/MHC complex enables TCR neoantigen selectivityJiaqi Ma, Cory M Ayres, Chad A Brambley, et al.

Biorxiv : the Preprint Server for Biology|February 26, 2024

Distinct sets of molecular characteristics define tumor-rejecting neoantigensAnngela C Adams, Anne M Macy, Elizabeth S Borden, et al.

Protein Engineering, Design & Selection : PEDS|February 28, 2026

Expansion of the known Poly(Aspartic Acid) Hydrolases through the Identification of Four New PahZ1 HomologsJustin D Marsee, Chad A Brambley, Thi Ho, et al.

Journal for Immunotherapy of Cancer|October 22, 2025

Structural changes from wild-type define tumor-rejecting neoantigensAnngela C Adams, Anne M Macy, Elizabeth S Borden, et al.

Pageof 2